Ramtin Agah - 05 Jun 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role: Chief Medical Officer, Director
Signature: /s/ Ramtin Agah
Issuer symbol: RNXT
Transactions as of: 05 Jun 2025
Net transactions value: +$29,400
Form type: 4
Filing time: 09 Jun 2025, 06:03:27 UTC
Previous filing: 06 Jun 2025
Next filing: 03 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Agah Ramtin	Chief Medical Officer, Director	C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW	/s/ Ramtin Agah	09 Jun 2025	0001862617

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNXT	Common Stock	Purchase	$29,400	+21,000	+2.9%	$1.40	734,460	05 Jun 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects open market purchases of the Issuer's securities.
F2	The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.